Annual CFO
-$6.14 M
+$12.36 M+66.83%
31 December 2023
Summary:
Galmed Pharmaceuticals annual cash flow from operations is currently -$6.14 million, with the most recent change of +$12.36 million (+66.83%) on 31 December 2023. During the last 3 years, it has risen by +$20.15 million (+76.65%). GLMD annual CFO is now -143.15% below its all-time high of -$2.52 million, reached on 31 December 2013.GLMD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.06 M
-$47.00 K-4.62%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly cash flow from operations is currently -$1.06 million, with the most recent change of -$47.00 thousand (-4.62%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+51.13%). GLMD quarterly CFO is now -540.96% below its all-time high of -$166.00 thousand, reached on 30 June 2013.GLMD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$4.81 M
+$1.11 M+18.79%
30 September 2024
Summary:
Galmed Pharmaceuticals TTM cash flow from operations is currently -$4.81 million, with the most recent change of +$1.11 million (+18.79%) on 30 September 2024. Over the past year, it has increased by +$4.45 million (+48.08%). GLMD TTM CFO is now -966.30% below its all-time high of -$451.00 thousand, reached on 31 March 2013.GLMD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.8% | +51.1% | +48.1% |
| 3 y3 years | +76.7% | +88.2% | +85.8% |
| 5 y5 years | +32.0% | +72.5% | +63.4% |
GLMD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +81.3% | -18.5% | +88.2% | at high | +85.8% |
| 5 y | 5 years | at high | +81.3% | -18.5% | +88.5% | at high | +85.8% |
| alltime | all time | -143.2% | +81.3% | -541.0% | +88.5% | -966.3% | +85.8% |
Galmed Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.06 M(+4.6%) | -$4.81 M(-18.8%) |
| June 2024 | - | -$1.02 M(-44.4%) | -$5.92 M(-5.6%) |
| Mar 2024 | - | -$1.83 M(+103.8%) | -$6.27 M(+2.2%) |
| Dec 2023 | -$6.14 M(-66.8%) | -$898.00 K(-58.8%) | -$6.14 M(-33.7%) |
| Sept 2023 | - | -$2.18 M(+59.3%) | -$9.26 M(-9.2%) |
| June 2023 | - | -$1.37 M(-19.4%) | -$10.20 M(-30.8%) |
| Mar 2023 | - | -$1.70 M(-57.9%) | -$14.74 M(-20.3%) |
| Dec 2022 | -$18.50 M(-43.8%) | -$4.02 M(+29.2%) | -$18.50 M(-13.8%) |
| Sept 2022 | - | -$3.11 M(-47.3%) | -$21.47 M(-21.5%) |
| June 2022 | - | -$5.91 M(+8.4%) | -$27.34 M(-5.9%) |
| Mar 2022 | - | -$5.45 M(-22.0%) | -$29.06 M(-11.7%) |
| Dec 2021 | -$32.89 M(+25.1%) | -$6.99 M(-22.2%) | -$32.89 M(-2.5%) |
| Sept 2021 | - | -$8.98 M(+17.7%) | -$33.74 M(+11.1%) |
| June 2021 | - | -$7.63 M(-17.8%) | -$30.36 M(+4.8%) |
| Mar 2021 | - | -$9.29 M(+18.5%) | -$28.98 M(+10.3%) |
| Dec 2020 | -$26.29 M(+76.0%) | -$7.84 M(+39.8%) | -$26.29 M(+16.8%) |
| Sept 2020 | - | -$5.61 M(-10.3%) | -$22.52 M(+8.4%) |
| June 2020 | - | -$6.25 M(-5.1%) | -$20.78 M(+17.4%) |
| Mar 2020 | - | -$6.59 M(+62.0%) | -$17.70 M(+18.5%) |
| Dec 2019 | -$14.94 M(+65.5%) | -$4.07 M(+5.1%) | -$14.94 M(+13.8%) |
| Sept 2019 | - | -$3.87 M(+21.6%) | -$13.12 M(+18.1%) |
| June 2019 | - | -$3.18 M(-16.7%) | -$11.11 M(+18.5%) |
| Mar 2019 | - | -$3.82 M(+69.8%) | -$9.38 M(+3.9%) |
| Dec 2018 | -$9.02 M | -$2.25 M(+20.9%) | -$9.02 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.86 M(+28.6%) | -$9.26 M(-10.0%) |
| June 2018 | - | -$1.45 M(-58.2%) | -$10.29 M(-11.7%) |
| Mar 2018 | - | -$3.46 M(+39.5%) | -$11.66 M(-3.4%) |
| Dec 2017 | -$12.07 M(-0.5%) | -$2.48 M(-14.2%) | -$12.07 M(-2.7%) |
| Sept 2017 | - | -$2.89 M(+2.8%) | -$12.41 M(-2.5%) |
| June 2017 | - | -$2.81 M(-27.3%) | -$12.72 M(-1.5%) |
| Mar 2017 | - | -$3.87 M(+37.2%) | -$12.92 M(+6.5%) |
| Dec 2016 | -$12.13 M(+43.1%) | -$2.82 M(-12.1%) | -$12.13 M(+5.2%) |
| Sept 2016 | - | -$3.21 M(+6.6%) | -$11.53 M(+9.0%) |
| June 2016 | - | -$3.01 M(-2.2%) | -$10.58 M(+13.8%) |
| Mar 2016 | - | -$3.08 M(+38.2%) | -$9.30 M(+9.7%) |
| Dec 2015 | -$8.47 M(-8.3%) | -$2.23 M(-1.5%) | -$8.47 M(-4.3%) |
| Sept 2015 | - | -$2.26 M(+30.9%) | -$8.86 M(+2.4%) |
| June 2015 | - | -$1.73 M(-23.4%) | -$8.65 M(-6.8%) |
| Mar 2015 | - | -$2.26 M(-13.6%) | -$9.28 M(+0.4%) |
| Dec 2014 | -$9.24 M(+266.1%) | -$2.61 M(+27.2%) | -$9.24 M(+22.6%) |
| Sept 2014 | - | -$2.05 M(-13.1%) | -$7.54 M(+16.3%) |
| June 2014 | - | -$2.36 M(+6.5%) | -$6.49 M(+51.2%) |
| Mar 2014 | - | -$2.22 M(+143.9%) | -$4.29 M(+70.0%) |
| Dec 2013 | -$2.52 M(-18.0%) | -$909.00 K(-8.9%) | -$2.52 M(+56.3%) |
| Sept 2013 | - | -$998.00 K(+501.2%) | -$1.61 M(+161.8%) |
| June 2013 | - | -$166.00 K(-63.2%) | -$617.00 K(+36.8%) |
| Mar 2013 | - | -$451.00 K | -$451.00 K |
| Dec 2012 | -$3.08 M | - | - |
FAQ
- What is Galmed Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual CFO year-on-year change?
- What is Galmed Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly CFO year-on-year change?
- What is Galmed Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM CFO year-on-year change?
What is Galmed Pharmaceuticals annual cash flow from operations?
The current annual CFO of GLMD is -$6.14 M
What is the all time high annual CFO for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual cash flow from operations is -$2.52 M
What is Galmed Pharmaceuticals annual CFO year-on-year change?
Over the past year, GLMD annual cash flow from operations has changed by +$12.36 M (+66.83%)
What is Galmed Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of GLMD is -$1.06 M
What is the all time high quarterly CFO for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly cash flow from operations is -$166.00 K
What is Galmed Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, GLMD quarterly cash flow from operations has changed by +$1.11 M (+51.13%)
What is Galmed Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of GLMD is -$4.81 M
What is the all time high TTM CFO for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM cash flow from operations is -$451.00 K
What is Galmed Pharmaceuticals TTM CFO year-on-year change?
Over the past year, GLMD TTM cash flow from operations has changed by +$4.45 M (+48.08%)